| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $14.1M | +91.4% |
| SG&A Expense | $14.5M | +97.9% |
| Operating Income | -$28.5M | -94.6% |
| Income Tax | $0 | — |
| Net Income | -$28.5M | -94.6% |
| EPS (Basic) | -$1.36 | +7.5% |
| EPS (Diluted) | -$1.36 | +7.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Current Assets | $22.2M | -43.0% |
| Total Assets | $33.0M | -21.8% |
| Current Liabilities | $5.8M | +158.1% |
| Total Liabilities | $10.3M | +155.1% |
| Stockholders' Equity | $22.7M | -40.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.1M | -78.6% |
| Investing Cash Flow | -$3.7M | -1099.0% |
| Financing Cash Flow | $9.0M | -72.7% |